Novo Nordisk: FDA posts briefing materials prior to Advisory Committee meeting for semaglutide
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via GlobeNewswire
Upcoming Life Sciences Events
- April 2024
- London: LSX World Congress
- May 2024
- Seoul: BIO KOREA 2024
- Biotechgate Digital Partnering May 2024
Latest company news
There are currently no news available for this portal